Publication | Open Access

Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease

InflammationChronic Inflammatory DiseasesAnti-inflammatoryAllergyAutoimmune DiseaseMucosal ImmunologyImmunologyGastroenterologyChronic InflammationLong-term OutcomeInfliximab OptimizationAutoimmunityUlcerative ColitisImmunotherapyMedicine